GeneInsight Bio Platform
24-Module Bioinformatics Clinical Platform with Mol* 3D Protein Visualization
The Enterprise Problem & Core Constraints
Genomics researchers and clinical oncologists must consult dozens of disparate biomedical databases (NCBI ClinVar, UniProt, gnomAD, PDB) to evaluate the pathogenicity of patient genetic mutations, spending dozens of hours manually verifying literature citations.
AxonFlow AI engineered GeneInsight Bio Platform: an all-in-one clinical decision support suite featuring 24 integrated omics modules. Clinicians query patient gene mutations to receive automated pathogenicity classifications, real-time AlphaFold / Mol* 3D structural protein renders, and curated clinical trial links.
Quantified Business ROI
Shortened genomic variant analysis workflows from 4 hours to under 3 minutes per case. Utilized by university genetics laboratories and clinical oncology teams across 18 academic research centers.
Multi-Tier Production Architecture
Unified Omics Pipeline
Aggregates REST APIs from NCBI E-utilities, UniProt, Ensembl, and ClinVar into a normalized clinical evidence graph.
AlphaFold 3D Visualizer
Embedded Mol* WebGL viewer rendering protein secondary structures, active binding pockets, and amino acid missense mutation sites.
Variant Impact Scoring
Automated clinical impact classifier predicting loss-of-function likelihood, conservation scores (PhyloP), and drug tractability.
PubMed Clinical Linker
Semantic literature search extracting peer-reviewed clinical trial references matching specific patient genomic variations.
Enterprise Technical Specifications
Live Production Application Preview
Need a Custom System Built with This Architecture?
AxonFlow AI takes enterprise software from initial architectural scoping to live production deployment with guaranteed uptime SLAs and complete code ownership.